UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 15.

Veit-Haibach, P; Schmid, D; Strobel, K; Soyka, J D; Schaefer, N G; Haerle, S K; Huber, G F; Studer, G; Seifert, Burkhardt; Hany, T F (2013). Combined PET/CT-perfusion in patients with head and neck cancers. European Radiology, 23(1):163-173.

Schaefer, N G; Veit-Haibach, P; Soyka, J D; Steinert, H C; Stahel, R A (2012). Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): Value of 18F-FDG-PET/CT. European Journal of Radiology, 81(1):e19-e25.

Veit-Haibach, P; Schiesser, M; Soyka, J; Strobel, K; Schaefer, N G; Hesselmann, R; Clavien, P A; Hany, T F (2011). Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component. European Radiology, 21(2):256-264.

Burger, I A; Husmann, L; Hany, T F; Schmid, D T; Schaefer, N G (2011). Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine. Clinical Nuclear Medicine, 36(10):848-853.

Schaefer, N G; James, E; Wahl, R L (2011). Poly(ADP-ribose) polymerase inhibitors combined with external beam and radioimmunotherapy to treat aggressive lymphoma. Nuclear Medicine Communications, 32(11):1046-1051.

Schaefer, N G; Huang, P; Buchanan, J W; Wahl, R L (2011). Radioimmunotherapy in non-Hodgkin lymphoma: opinions of nuclear medicine physicians and radiation oncologists. Journal of Nuclear Medicine, 52(5):830-838.

Mischo, A; Bubel, N; Cebon, J S; Samaras, P; Petrausch, U; Stenner-Liewen, F; Schaefer, N G; Kubuschok, B; Renner, C; Wadle, A (2011). Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis. International Journal of Oncology, 39(1):287-294.

Veit-Haibach, P; Treyer, V; Strobel, K; Soyka, J D; Husmann, L; Schaefer, N G; Tschopp, A; Hany, T F (2010). Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdominal Imaging, 35(5):528-536.

Petrausch, U; Samaras, P; Veit-Haibach, P; Tschopp, A; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schaefer, N G (2010). Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? Annals of Oncology, 21(5):1053-1057.

Samaras, P; Heider, H; Haile, S R; Petrausch, U; Schaefer, N G; Siciliano, R D; Meisel, A; Mischo, A; Zweifel, M; Knuth, A; Stenner-Liewen, F; Renner, C (2010). Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP. Annals of Hematology, 89(8):783-787.

Veit-Haibach, P; Schaefer, N G; Steinert, H C; Soyka, J D; Seifert, B; Stahel, R A (2010). Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer, 67(3):311-317.

Soyka, J D; Strobel, K; Veit-Haibach, P; Schaefer, N G; Schmid, D T; Tschopp, A; Hany, T F (2010). Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine. Journal of Nuclear Medicine, 51(4):507-510.

Schaefer, N G; Ma, J; Huang, P; Buchanan, J; Wahl, R L (2010). Radioimmunotherapy in non-Hodgkin lymphoma: opinions of U.S. medical oncologists and hematologists. Journal of Nuclear Medicine, 51(6):987-994.

Waibel, R; Treichler, H; Schaefer, N G; van Staveren, D R; Mundwiler, S; Kunze, S; Küenzi, M; Alberto, R; Nüesch, J; Knuth, A; Moch, H; Schibli, R; Schubiger, P A (2008). New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Research, 68(8):2904-2911.

Schaefer, N G; Hany, T F; Taverna, C; Seifert, Burkhardt; Stumpe, K D M; von Schulthess, G K; Goerres, G W (2004). Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? Radiology, 232(3):823-829.

This list was generated on Sun Jul 23 21:35:13 2017 CEST.